Connect with us

Business

U.S. Food and Drug Administration Approves Gilead’s Antiviral Veklury® (remdesivir) for Treatment of COVID-19 – Yahoo Finance

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury® (remdesivir…

Published

on

post featured image
ADVERTISEMENT

— Veklury Is First and Only FDA-Approved Treatment for COVID-19 in the United States —
— Veklury Shortened Time to Recovery By Five Days in Hospitalized COVID-19 Patients —
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury® (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication of SARS-CoV-2, the virus that causes COVID-19….

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Dam releases, bank failures and poisoned water: Cyber pros warn worst cases are possible – USA TODAY
Article feature image
Wage Gains at Factories Fall Behind Growth in Fast Food – The Wall Street Journal
Article feature image
New Alzheimer’s Drug Could Cost the Government as Much as It Spends on NASA – The New York Times